此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Diagnosis of Tuberculosis Infection in HIV Co-infected Children (ThrasherIGRA)

2022年1月3日 更新者:Anna Maria Mandalakas、Case Western Reserve University

Background: The TB and HIV epidemics are closely linked in developing countries, where 450,000 children die from HIV annually. TB is a major cause of death in HIV-infected children and is reversing gains made in child survival.

The traditional tuberculin skin test (TST) has limited diagnostic accuracy for detecting TB infection. Adult studies suggest that new blood-based diagnostic TB testing offers a quicker, more accurate way to diagnose TB infection. Such diagnostic testing may directly guide clinical management and preventive strategies in immune-suppressed HIV-infected children, who are at high risk of becoming TB diseased following infection. Data regarding the usefulness of these tests in children is currently limited.

Objective(s) and Hypothesis(es): The investigators hypothesize that blood-based TB diagnostic testing can accurately identify children with TB infection. In a community with high rates of TB and HIV infection, the following specific aims will be investigated in HIV-infected and uninfected children:

  1. assess the agreement between the TST and blood-based diagnostic testing,
  2. compare the performance of the TST and blood-based diagnostic testing to a standardized history of TB exposure,
  3. measure the impact of age, nutritional and immune status on children's response to blood-based testing,
  4. describe factors that might modify children's response to testing over time, and 5) examine the effect of environmental exposures and previous vaccination on the TST, blood-based testing and other measures of immune responses to TB.

Potential Impact: The benefits of an accurate, rapid diagnostic test of TB infection in children include 1) timely institution of treatment for TB infection to prevent severe disease and mortality, and 2) preclusion of over diagnosis and treatment. Treatment of childhood TB infection also prevents future contagious adult disease, thus decreasing community transmission. Blood-based diagnostic testing may also be able to identify children that are more likely to become ill following TB infection. Therefore, blood-based diagnostic testing has great potential to improve TB control and the health of HIV-infected and uninfected children, their households and communities.

研究概览

研究类型

观察性的

注册 (实际的)

250

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Western Cape
      • Tygerberg、Western Cape、南非、07505
        • Despond TuTu TB Centre, Stellenbosch University

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

3个月 至 15年 (孩子)

接受健康志愿者

有资格学习的性别

全部

取样方法

非概率样本

研究人群

HIV seropositive and seronegative South African children (6months to 15years) with and without M.tb exposure

描述

Inclusion Criteria:

  • age less than 15 years
  • completion of informed consent

Exclusion Criteria:

  • less than 3 months of age
  • documented anemia
  • recent diagnosis of tuberculosis
  • receiving treatment for tuberculosis

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

队列和干预

团体/队列
B
M.tb unexposed HIV-infected and uninfected children <15 years of age
A
M.tb exposed HIV-infected and uninfected children <15 years of age

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 首席研究员:Anna M Mandalakas, MD, PhD、Baylor College of Medicine
  • 首席研究员:Anneke C Hesseling, MD, MS、University of Stellenbosch

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2008年1月15日

初级完成 (实际的)

2011年2月22日

研究完成 (实际的)

2011年2月22日

研究注册日期

首次提交

2007年10月5日

首先提交符合 QC 标准的

2007年10月9日

首次发布 (估计)

2007年10月10日

研究记录更新

最后更新发布 (实际的)

2022年1月18日

上次提交的符合 QC 标准的更新

2022年1月3日

最后验证

2022年1月1日

更多信息

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

艾滋病毒感染的临床试验

3
订阅